as Egypt suffered a lot during the pandemic of COVID 19 with limited drug choices, many of the patients could not acheive viral clearence with the standard module of care teh idea of introduction of new medications in the treatment protocol of COVID 19 managment. Ivermectin had shown a promising results in vitro studies and in limited in vivo studies. this clinical trial may open a new hope for COVID 19 patients as a new and cheap line of treatment
the study will compare the effect of ivermectin in comaprison and addition to the standard mode of care for the COVID 19 patients
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
100
use of Ivermectin in the treatment of COVID 19 patients, in comparison to and in addition to the standard care of treatment of COVID 19 in Egypt
isolation and referal hospitals for COVID 19 patients
Cairo, Egypt
RECRUITINGto evaluate the role of Ivermectin as a line of treatment for COVID 19
the role of ivermectin in the cure of COVID 19 patients
Time frame: 2 months
To asses the rate of viral clearance in comparison to other treatment protocols.
to compare the results of ivermectin with the standard care
Time frame: 2 months
noha mo asem, MD
CONTACT
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.